The Trump administration’s cuts to university research grants will make America sicker and poorer in the long run.

Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite ...

AMN Healthcare Services said Mark Foletta was named its new chairman of the board. He succeeds Douglas Wheat, who had served on the board since 1999.

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...